Showing results (101-110 of 991) with videos related to

Sort By:
Pageof 100
Assay and Drug Development Technologies|June 13, 2015
Development and Use of Assay Conditions Suited to Screening for and Profiling of SET-Domain-Targeted Inhibitors of the MLL/SET1 Family of Lysine MethyltransferasesJoseph J Ferry, Robert F Smith, Natalie Denney, et al.
Assay and Drug Development Technologies|June 13, 2015
Comparison of a High-Throughput Mass Spectrometry Method and Radioactive Filter Binding to Assay the Protein Methyltransferase PRMT5Karen A Maegley, Cody Krivacic, Patrick Bingham, et al.
Assay and Drug Development Technologies|July 1, 2015
A Cellular Assay for Inhibitors of the Fatty Acid Biosynthetic Pathway Using Scintillating MicroplatesThao Ung, Jennifer L Mason, Ron G Robinson, et al.
Assay and Drug Development Technologies|June 13, 2015
Visualization of Time-Dependent Distribution of Rifampicin in Rat Brain Using MALDI MSI and Quantitative LCMS/MSAdeola Shobo, Dominika Bratkowska, Sooraj Baijnath, et al.
Assay and Drug Development Technologies|August 10, 2016
Analytical Characteristics of a Noninvasive Gene Expression Assay for Pigmented Skin LesionsZuxu Yao, Talisha Allen, Margaret Oakley, et al.
Assay and Drug Development Technologies|March 14, 2008
Optimization and utilization of the SureFire phospho-STAT5 assay for a cell-based screening campaignChristina Binder, Amy Lafayette, Ivonne Archibeque, et al.
Assay and Drug Development Technologies|July 20, 2007
Ultrasensitive cell-based bioassay for the measurement of global estrogenic activity of flavonoid mixtures revealing additive, restrictive, and enhanced actions in binary and higher order combinationsShih Peng Wong, Jun Li, Ping Shen, et al.
Assay and Drug Development Technologies|July 20, 2007
Recommendations for the reduction of compound artifacts in time-resolved fluorescence resonance energy transfer assaysPierre-Eloi Imbert, Vincent Unterreiner, Daniela Siebert, et al.
Assay and Drug Development Technologies|September 2, 2006
High throughput screening identified a substituted imidazole as a novel RANK pathway-selective osteoclastogenesis inhibitorTaosheng Chen, Anita C Knapp, Yang Wu, et al.
Assay and Drug Development Technologies|September 2, 2006
Enzyme fragment complementation binding assay for p38alpha mitogen-activated protein kinase to study the binding kinetics of enzyme inhibitorsGuido J R Zaman, Miranda M C van der Lee, Jacobus J Kok, et al.
Pageof 100